Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19 - a Post-hoc Analysis of the Blinded, Randomized COVID STEROID 2 Trial

NCT05195242 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05195242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05195242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19 - a Post-hoc Analysis of the Blinded, Randomized COVID STEROID 2 Trial
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Completed
Start date
August 27, 2020
Completion date
June 30, 2021
Enrollment
445 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, covid-19, thrombosis embolism